A case of apparent mineralocorticoid excess due to 11 beta HSD2 deficiency.

被引:0
|
作者
Morineau, G
Pascoe, L
Marc, JM
Caillette, A
Krozowski, Z
Corvol, P
Fiet, J
机构
[1] COLL FRANCE, INSERM U36, F-75005 PARIS, FRANCE
[2] CTR HOSP GEN, SERV NEPHROL, F-07103 ANNONAY, FRANCE
[3] HOP EDOUARD HERRIOT, SERV NEPHROL, F-69437 LYON, FRANCE
[4] BAKER MED RES INST, LAB MOL HYPERTENS, MELBOURNE, VIC 3181, AUSTRALIA
来源
ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX | 1997年 / 90卷 / 08期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The syndrome of apparent mineralocorticoid excess is a recessively inherited form of low renin hypertension. The syndrome is characterised by sodium retention and hypervolemia despite low plasma renin activity, and aldosterone levels. Patients with this syndrome have mutations in the 11HSD2 gene which encodes the enzyme which normally converts cortisol in the renal tubule to its inactive form, cortisone. The unconverted cortisol is thus able to bind and activate the mineralocorticoid receptor, displacing its usual ligand, aldosterone, causing the apparent mineralocorticoid excess. We have studied a patient with severe hypertension, low renin and aldosterone. and a chronic hypokalemic alkalosis at age 4. The analysis of cortisone, cortisol and their metabolites showed the specific pattern of the apparent mineralocorticoid excess. In serum and urine, there was a dramatic decrease of cortisone and its metabolite, while cortisol and its metabolites were non affected.
引用
收藏
页码:1111 / 1115
页数:5
相关论文
共 50 条
  • [31] Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene
    Lavery, GG
    Ronconi, V
    Draper, N
    Rabbitt, EH
    Lyons, V
    Chapman, KE
    Walker, EA
    McTernan, CL
    Giacchetti, G
    Mantero, F
    Seckl, JR
    Edwards, CRW
    Connell, JMC
    Hewison, M
    Stewart, PM
    HYPERTENSION, 2003, 42 (02) : 123 - 129
  • [32] Heterozygous HSD11B2 Gene Mutations and Apparent Mineralocorticoid Excess (AME) in a Patient with Heterozygous ADPKD1
    Chang, Celeste S.
    Liu, Hsiang C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 412 - 412
  • [33] Sex Differences Of Renal11[beta]-hsd1 And 11[beta]-hsd2 Expression In A Doca-salt Model Of Hypertension
    Belanger, Kasey
    Sullivan, Jennifer C.
    HYPERTENSION, 2021, 78
  • [34] Spironolactone Effective Hypertension in the Elderly Due to 11β-hydroxysteroid Dehydrogenase Type 2 (11β-HSD2) Impairment: Contributory Role of Determining Serum Cortisol/Cortisone Ratio as a Marker of 11β-HSD2 Activity
    Inada, Mitsuo
    Iwasaki, Keiko
    Imai, Chihiro
    Hashimoto, Satoshi
    INTERNAL MEDICINE, 2008, 47 (24) : 2157 - 2164
  • [35] Contribution of placental 11β-HSD2 to the pathogenesis of preeclampsia
    Wang, Gang
    Huang, Yan
    Hu, Tianxiao
    Zhang, Baozhen
    Tang, Zhengshan
    Yao, Ruojing
    Huang, Ying
    Fan, Xiujun
    Ni, Xin
    FASEB JOURNAL, 2020, 34 (11): : 15379 - 15399
  • [36] Two homozygous mutations in the 11β-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess
    Carvajal, CA
    Gonzalez, AA
    Romero, DG
    González, A
    Mosso, LM
    Lagos, ET
    Hevia, MD
    Rosati, MP
    Perez-Acle, TO
    Gomez-Sanchez, CE
    Montero, JA
    Fardella, CE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06): : 2501 - 2507
  • [37] Evaluation of the 11β-HSD2 gene in diabetes mellitus
    Ringel, J
    Brand, E
    Distier, A
    Sharma, AM
    HYPERTENSION, 1999, 34 (04) : 707 - 707
  • [38] Hypertensive Patients That Respond to Aldosterone Antagonists May Have a Nonclassical 11β-HSD2 Deficiency
    Tapia-Castillo, Alejandra
    Carvajal, Cristian A.
    Allende, Fidel
    Campino, Carmen
    Fardella, Carlos E.
    AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (08) : E6 - E6
  • [39] THE SYNDROME OF APPARENT MINERALOCORTICOID EXCESS - ITS ASSOCIATION WITH 11 BETA-DEHYDROGENASE AND 5 BETA-REDUCTASE DEFICIENCY AND SOME CONSEQUENCES FOR CORTICOSTEROID METABOLISM
    MONDER, C
    SHACKLETON, CHL
    BRADLOW, HL
    NEW, MI
    STONER, E
    IOHAN, F
    LAKSHMI, V
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (03): : 550 - 557
  • [40] Foetal and placental 11β-HSD2: a hub for developmental programming
    Cottrell, E. C.
    Seckl, J. R.
    Holmes, M. C.
    Wyrwoll, C. S.
    ACTA PHYSIOLOGICA, 2014, 210 (02) : 288 - 295